These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11602536)

  • 1. Gene therapy for coronary restenosis: is the enthusiasm justified?
    O'Sullivan M; Bennett MR
    Heart; 2001 Nov; 86(5):491-3. PubMed ID: 11602536
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy for restenosis--what now, what next?
    Appleby CE; Kingston PA
    Curr Gene Ther; 2004 Jun; 4(2):153-82. PubMed ID: 15180583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis and gene therapy.
    Quarck R; Holvoet P
    Expert Opin Biol Ther; 2001 Jan; 1(1):79-91. PubMed ID: 11727549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.
    Mitra AK; Agrawal DK
    Pharmacogenomics; 2006 Dec; 7(8):1185-98. PubMed ID: 17184206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for cardiovascular disease.
    Kozarsky KF
    Curr Opin Pharmacol; 2001 Apr; 1(2):197-202. PubMed ID: 11714096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticulate carriers for the treatment of coronary restenosis.
    Brito L; Amiji M
    Int J Nanomedicine; 2007; 2(2):143-61. PubMed ID: 17722543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.
    Hall S; Agrawal DK
    Drug Deliv Transl Res; 2018 Aug; 8(4):918-927. PubMed ID: 28707263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis.
    Fishbein I; Guerrero DT; Alferiev IS; Foster JB; Minutolo NG; Chorny M; Monteys AM; Driesbaugh KH; Nagaswami C; Levy RJ
    Gene Ther; 2017 Nov; 24(11):717-726. PubMed ID: 28832561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral transfer of endothelial nitric oxide synthase attenuates lesion formation in a novel murine model of postangioplasty restenosis.
    von der Thüsen JH; Fekkes ML; Passier R; van Zonneveld AJ; Mainfroid V; van Berkel TJ; Biessen EA
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):357-62. PubMed ID: 14699016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for restenosis: are we ready?
    DeYoung MB; Dichek DA
    Circ Res; 1998 Feb; 82(3):306-13. PubMed ID: 9486658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy of restenosis and atherosclerosis: hopes and facts].
    Mazighi M; Tchétché D; Hyafil F; Feldman LJ
    Pathol Biol (Paris); 2004 May; 52(4):212-7. PubMed ID: 15145134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy in interventional coronary interventions].
    Buchwald AB
    Herz; 2002 Sep; 27(6):533-8. PubMed ID: 12378399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus.
    Klugherz BD; Song C; DeFelice S; Cui X; Lu Z; Connolly J; Hinson JT; Wilensky RL; Levy RJ
    Hum Gene Ther; 2002 Feb; 13(3):443-54. PubMed ID: 11860711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for vein graft failure.
    Wang XW; Zhao XJ; Xiang XY
    J Card Surg; 2013 Mar; 28(2):144-7. PubMed ID: 23414326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for bypass graft failure and restenosis.
    Baker AH
    Pathophysiol Haemost Thromb; 2002; 32(5-6):389-91. PubMed ID: 13679682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-intervention vessel remodeling.
    Rutanen J; Puhakka H; Ylä-Herttuala S
    Gene Ther; 2002 Nov; 9(22):1487-91. PubMed ID: 12407420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of gene therapy in the treatment of cardiovascular diseases.
    Barbato JE; Kibbe MR; Tzeng E
    Crit Rev Clin Lab Sci; 2003 Oct; 40(5):499-545. PubMed ID: 14653356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo.
    Richter M; Iwata A; Nyhuis J; Nitta Y; Miller AD; Halbert CL; Allen MD
    Physiol Genomics; 2000 Apr; 2(3):117-27. PubMed ID: 11015590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G; Aycock JK; Frati G; Napoli C
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.